EQT Life Sciences, Droia Ventures, and Sanofi Ventures led the round Financing supports clinical activities for Company’s two lead programs in ALS and pipeline development CAMBRIDGE, Mass., March 9, 2023 /PRNewswire/ — QurAlis Corporation, a clinical-stage biotechnology company…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.